Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiation Retinopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableActive Not RecruitingNCT03026998
What this trial is testing

MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)

Who this might be right for
Hereditary Retinoblastoma
Institut Curie 88
Large-scale testing (Phase 3)UnknownNCT00811200
What this trial is testing

Treatment Of Radiation Retinopathy Trial

Who this might be right for
Uveal Melanoma
Leiden University Medical Center 220
Not applicableEnded earlyNCT01415453
What this trial is testing

Evoked Retinal Response

Who this might be right for
Retinitis Pigmentosa
Columbia University 1
Testing effectiveness (Phase 2)UnknownNCT01521065
What this trial is testing

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationWet Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 500
Not applicableUnknownNCT01521819
What this trial is testing

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Who this might be right for
Retinal Pigment Epithelial Detachment With VascularizationAge Related Macular Degeneration
Oraya Therapeutics, Inc. 12
Not applicableStudy completedNCT01833325
What this trial is testing

Proton Radiation Therapy for Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Florida 9
Early research (Phase 1)Ended earlyNCT00623077
What this trial is testing

MT2004-30: Tomotherapy for Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more
Masonic Cancer Center, University of Minnesota 23
Not applicableUnknownNCT01516294
What this trial is testing

IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD

Who this might be right for
Polypoidal Chorodial VasculopathyAge Related Macular Degeneration
Oraya Therapeutics, Inc. 12
Large-scale testing (Phase 3)UnknownNCT00454389
What this trial is testing

Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
NeoVista 494
Not applicableUnknownNCT02483650
What this trial is testing

Hyperbaric Oxygen Therapy Registry

Who this might be right for
Air or Gas EmbolismCarbon Monoxide PoisoningClostridial Myositis and Myonecrosis (Gas Gangrene)+11 more
U.S. Wound Registry 5,000
Very early researchStudy completedNCT00517010
What this trial is testing

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
University of California, Davis 6
Testing effectiveness (Phase 2)Study completedNCT02586727
What this trial is testing

Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy

Who this might be right for
Adverse Effect of Radiation Therapy
Larkin Community Hospital 40
Early research (Phase 1)Study completedNCT01579760
What this trial is testing

Intravitreal Aflibercept Injection for Radiation Retinopathy

Who this might be right for
Radiation RetinopathyMacular Edema
Washington University School of Medicine 9
Early research (Phase 1)Study completedNCT01334879
What this trial is testing

High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy

Who this might be right for
Radiation Retinopathy
The New York Eye Cancer Center 10